About the Journal
"[T]he simple word Care may suffice to express [the journal’s] philosophical mission", "to promote better patient care by serving the expanded needs of all health professionals committed to the care of patients with diabetes." More.
2022 JCR Metrics
Impact Factor 16.2 (6th)
Total Citations 83,788 (2nd)
Eigenfactor 0.07696 (1st)
Learn More

Diabetes Care "On Air"
Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they interview authors and discuss the latest high-impact research published in each monthly issue of Diabetes Care. Available from most podcasting platforms.
Listen and follow today on Apple Podcasts | Google Play | Amazon Music | Spotify
Current Issue Highlights
Volume 46, Issue 12



Prediabetic HbA1c and Cortical Atrophy: Underlying Neurobiology
Access the complete Table of Contents.
Submit your artwork for the cover of Diabetes Care
Calling all artists impacted by diabetes! Please consider submitting your original artwork for publication on the cover of an issue of Diabetes Care. Any subject or medium is welcome. Learn more.

Follow Diabetes Care on X
Join us on X @DiabetesCareADA to learn about recently published articles, along with your diabetes research community, and share ideas with fellow professionals. Find the newest published articles, information on related ADA podcasts, new professional book titles, and up-to-date diabetes news items. You can also follow ADA Publications on Facebook @adaPublications.
New Economic Costs Statement Reports the Annual Costs of Diabetes in the U.S.
The latest Economic Costs Statement reports the total annual costs of diabetes as $412.9 billion in 2022, and people with diagnosed diabetes now account for one of every four health care dollars spent in the U.S. The full report will appear in the December issue of Diabetes Care and is free to access online.

Standards of Care in Diabetes Clinical Practice Guideline Updates From the ADA
On 25 June 2023, ADA released important updates to the Standards of Care in Diabetes, including recommendations on teplizumab for delaying type 1 diabetes (Section 2 and Section 3) and recommendations for detection and management of NAFLD/NASH (Section 4). Access is free.
Diabetes Care "On Air" podcast
Listen here and follow on most podcast platforms.